CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The TIMER Consortium focuses on discovering and validating new molecules that promote the resolution of inflammation, aiming to develop innovative treatments for chronic inflammatory and autoimmune diseases. The project explores natural and synthetic compounds that regulate key inflammatory pathways to enhance healing…
Resolution of inflammation is a key determinant of pathology, and an active process which involves diverse pathways and molecules.
The general objective of the TIMER Consortium is to identify and validate new molecules involved in the resolution of inflammation as a basis for the development of innovative therapeutic strategies in chronic inflammatory and autoimmune diseases.
The project will involve discovery of new natural or synthetic “pro-resolving” molecules for plant and animals and invest…
FONDAZIONE HUMANITAS PER LA RICERCA
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Italy, L'Aquila
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Brazil, Belo Horizonte Minas Gerais
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Brazil, Sao Paulo Sp
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
